Cadonilimab (AK104) Plus Lenvatinib in Previously Immunotherapy-Treated Advanced/Metastatic Clear Cell Renal Cell Carcinoma

Name: Cadonilimab (AK104) Plus Lenvatinib in Previously Immunotherapy-Treated Advanced/Metastatic Clear Cell Renal Cell Carcinoma
License: Public Domain

RenJi Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

clear cell renal cell carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 426786
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.